BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Honoré N, Galot R, van Marcke C, Limaye N, Machiels JP. Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact. Cancers (Basel) 2021;13:5364. [PMID: 34771526 DOI: 10.3390/cancers13215364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Herrero C, Ferreirós A, Pérez-fentes D, León-mateos L, López-lópez R, Abal M, Alonso-alconada L. Extracellular Vesicles’ Genetic Cargo as Noninvasive Biomarkers in Cancer: A Pilot Study Using ExoGAG Technology. Biomedicines 2023;11:404. [DOI: 10.3390/biomedicines11020404] [Reference Citation Analysis]
2 Buttitta F, Navicella A, Rossetti R, Felicioni L, Marchetti A. Liquid biopsy: new challenges in the era of immunotherapy and precision oncology NGS and the other faces of molecular biology. Liquid Biopsy 2023. [DOI: 10.1016/b978-0-12-822703-9.00015-6] [Reference Citation Analysis]
3 Balla A, Bhak J, Biró O. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer. Mol Cell Probes 2022;66:101871. [PMID: 36283501 DOI: 10.1016/j.mcp.2022.101871] [Reference Citation Analysis]
4 Gumà J, Peña K, Riu F, Guilarte C, Hernandez A, Lucía C, Martínez-Madueño F, Miranda MJ, Cabezas I, Grifoll M, Peralta S, Serrano S, Muñoz F, Delamo L, Roig B, Borràs J, Badia J, Rodriguez-Balada M, Parada D. Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples. Cancers (Basel) 2022;14. [PMID: 36497340 DOI: 10.3390/cancers14235859] [Reference Citation Analysis]
5 Xie X, Li Y, Lian S, Lu Y, Jia L. Cancer metastasis chemoprevention prevents circulating tumour cells from germination. Signal Transduct Target Ther 2022;7:341. [PMID: 36184654 DOI: 10.1038/s41392-022-01174-w] [Reference Citation Analysis]
6 Horgan D, Baird A, Middleton M, Mihaylova Z, Van Meerbeeck JP, Vogel-claussen J, Van Schil PE, Malvehy J, Ascierto PA, Dube F, Zaiac M, Lal JA, Kamińska-winciorek G, Donia M, André T, Kozaric M, Osterlund P, Dumitrascu DL, Bertolaccini L. How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma? Healthcare 2022;10:1618. [DOI: 10.3390/healthcare10091618] [Reference Citation Analysis]
7 Derouane F, van Marcke C, Berlière M, Gerday A, Fellah L, Leconte I, Van Bockstal MR, Galant C, Corbet C, Duhoux FP. Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine. Cancers 2022;14:3876. [DOI: 10.3390/cancers14163876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Saidak Z, Galmiche A, Ouendo M, Chatelain D, Constans J, Testelin S. Principe et applicabilité de la chirurgie de précision aux cancers de la tête et du cou. Med Sci (Paris) 2022;38:562-569. [DOI: 10.1051/medsci/2022082] [Reference Citation Analysis]
9 Innaro N, Gervasi R, Ferrazzo T, Garo NC, Curto LS, Lavecchia A, Aquila I, Donato G, Malara N. Minimal residual disease assessment of papillary thyroid carcinoma through circulating tumor cell-based cytology. Cancer Med 2022;11:4830-7. [PMID: 35586892 DOI: 10.1002/cam4.4813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]